|
|
|
|
| LEADER |
01521nmm a2200325 u 4500 |
| 001 |
EB000691419 |
| 003 |
EBX01000000000000000544501 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
140122 ||| eng |
| 020 |
|
|
|a 9783662222416
|
| 100 |
1 |
|
|a Gulliya, Kirpal S.
|
| 245 |
0 |
0 |
|a Novel Chemotherapeutic Agents: Preactivation in the Treatment of Cancer and AIDS
|h Elektronische Ressource
|c by Kirpal S. Gulliya
|
| 250 |
|
|
|a 1st ed. 1996
|
| 260 |
|
|
|a Berlin, Heidelberg
|b Springer Berlin Heidelberg
|c 1996, 1996
|
| 300 |
|
|
|a XIII, 212 p. 46 illus
|b online resource
|
| 505 |
0 |
|
|a 1. Challenges and Opportunities in New Drug Development -- 2. Preactivation-Discovery and Biological Effects of Novel Chemotherapeutic Agents -- 3. Photochemistry and Photophysics of Merocyanine 540 -- 4. Preclinical Studies of Preactivated Merocyanine 540 and Merodantoin -- 5. The Role of Topoisomerases and Apoptosis in the Mechanism of Action of Preactivated Compounds -- 6. Modulation of Oncogenes with Preactivated Compounds -- Epilogue
|
| 653 |
|
|
|a Medicine / Research
|
| 653 |
|
|
|a Biology / Research
|
| 653 |
|
|
|a Cancer
|
| 653 |
|
|
|a Biomedical Research
|
| 653 |
|
|
|a Pharmacology
|
| 653 |
|
|
|a Cancer Biology
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
| 490 |
0 |
|
|a Medical Intelligence Unit
|
| 028 |
5 |
0 |
|a 10.1007/978-3-662-22241-6
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-662-22241-6?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616.994
|
| 082 |
0 |
|
|a 571.978
|